Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.

Translated title of the contribution: Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.

M.S. van der Veer, M. de Weers, B. van Kessel - Welmers, J.M. Bakker, S. Wittebol, P.W.H.I. Parren, H.M. Lokhorst, T. Mutis

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionTowards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.
Original languageUndefined/Unknown
Pages (from-to)284-290
Number of pages7
JournalHaematologica
Volume96
Issue number2
Publication statusPublished - 2011

Cite this